Cleary Gottlieb Steen & Hamilton LLP represented Sysco Corporation in the transaction. Sysco Corporation (NYSE: SYY) entered into an agreement to acquire Greco and Sons, a leading...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Luther advised StudySmarter on the deal. Greenberg Traurig advised Owl Ventures. Goodwin Procter advised Left Lane Capital. The Munich start-up StudySmarter has raised USD 15 million...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher LLP represented SCVX in the transaction, while Latham & Watkins LLP and Wolf Theiss represented Bright Machines. SCVX (NYSE: SCVX), a special...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vedere Bio II, Inc. on the deal. Vedere Bio II, Inc. announced its $77 million Series A financing. Vedere is developing next generation...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aadi Bioscience on the deal while Goodwin Procter LLP represented Aerpio Pharmaceuticals, Inc. Aerpio Pharmaceuticals and Aadi Bioscience announced their...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vedere Bio II, Inc. on the deal. Vedere Bio II, Inc. announced its $77 million Series A financing. Vedere is developing next generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, Willkie Farr and Evershed Sutherland advised Eurazeo on the dea. EY Société d’Avocats advised the founders and Hoche & Avocats advised Keensight Capital. Eurazeo,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Behrman Capital on the deal. Behrman Capital announced the completion of its bolt-on acquisition of contract research organization Orphan Reach via its portfolio...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Envisagenics on the deal. Envisagenics announced its collaboration with Biogen Inc. (Nasdaq: BIIB) to advance ribonucleic acid (RNA) splicing research within central nervous...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Goodwin Procter, advised on the matter. Goodwin Procter advised Magellan Partners with a team including Arnaud Fromion (Picture – Finance). Read the full article...
You must be a Standard 1 Year member to access this content.
